Valérie Durieux Selected Research

Valérie Durieux Research Topics

5	Neoplasms (Cancer) 10/2023 - 06/2019
5	Lung Neoplasms (Lung Cancer) 01/2023 - 01/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 07/2020
2	Obesity 04/2024 - 04/2024
2	Adenocarcinoma of Lung 10/2021 - 06/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2023
1	Carcinoid Tumor (Carcinoid) 01/2023
1	Infections 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	HIV Infections (HIV Infection) 01/2023
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2021
1	Ischemic Stroke 10/2021
1	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2019
1	Respiratory Tract Infections (Respiratory Tract Infection) 06/2019
1	Hemorrhage 06/2019
1	Critical Illness (Critically Ill) 06/2019
1	Pneumothorax 06/2019
1	Posterior Leukoencephalopathy Syndrome 06/2019
1	Rare Diseases (Rare Disease) 12/2018
1	Thymoma (Thymic Carcinoma) 12/2018
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2017

3	Immune Checkpoint InhibitorsIBA 10/2023 - 06/2019
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	Peptide Receptors (Peptide Receptor)IBA 01/2023
1	Everolimus FDA Link 01/2023
1	Radioisotopes (Radionuclides)IBA 01/2023
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2023
1	pembrolizumabIBA 10/2021
1	Tyrosine Kinase InhibitorsIBA 07/2021
1	CrizotinibIBA 06/2019
1	Bevacizumab (Avastin)FDA Link 06/2019
1	NivolumabIBA 06/2019
1	PlatinumIBA 12/2018
1	Etoposide (VP 16)FDA LinkGeneric 12/2018
1	Cisplatin (Platino)FDA LinkGeneric 12/2018
1	AnthracyclinesIBA 12/2018
1	AntibodiesIBA 01/2017

8	Therapeutics 04/2024 - 12/2018
7	Immunotherapy 10/2023 - 12/2018
2	Radiotherapy 01/2023 - 07/2020
2	Drug Therapy (Chemotherapy) 07/2020 - 12/2018
1	Palliative Care (Palliative Therapy) 01/2023
1	Thymectomy 01/2021
1	Immunomodulation 01/2021
1	Adjuvant Radiotherapy 12/2018